STAA (STAAR Surgical Corp) יחס שווי שוק לשווי בספרים
Scaling sales in Asia activates operating leverage, reducing the cost of goods sold while maintaining high gross margins. This chart of current share prices on GURU.Markets confirms STAAR Surgical Company (STAA) as the leader in implantable lenses, where a technological edge ensures excellent profitability and stable FCF. Surgeon loyalty to the unique instrumentation guarantees high-margin revenue, which currently stands at 3.29.
%20-%20%D7%99%D7%97%D7%A1%20%D7%A9%D7%95%D7%95%D7%99%20%D7%A9%D7%95%D7%A7%20%D7%9C%D7%A0%D7%9B%D7%A1%D7%99%D7%9D%20%D7%A0%D7%A7%D7%99%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_STAA_-_STAAR-Surgical-Company_-_Market-Cap-to-Net-Assets-Ratio "STAA יחס שווי שוק לערך בספרים STAAR Surgical (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
STAA (STAAR Surgical Co.): פילוחים אנליטיים ודוחות לפי אינדיקטורים
To identify fundamental stability drivers, the investor analyzes the price-to-book ratio, which allows for an assessment of the business's current premium over its book value. This metric, representing the excess of market value over balance sheet capital, reflects market confidence in the capitalization of STAAR Surgical Company (STAA) ESG initiatives regarding medical waste optimization and strict adherence to bioethical manufacturing standards.